States move to regulate private equity-backed autism therapy providers - Private Equity Stakeholder Project PESP

Private equity's penetration of autism therapy services has accelerated sharply over the past decade, with researchers at Brown University's Center for Advancing Health Policy through Research documenting 574 PE-owned autism therapy centers across 42 states as of 2024. These acquisitions resulted from 142 separate deals, with the majority—nearly 80%—executed between 2018 and 2022, representing one of the fastest consolidations in pediatric health care services. The data, published in JAMA Pediatrics, offers the first comprehensive national assessment of PE's role in autism service delivery and underscores the sector's transformation from fragmented provider networks into a concentrated, financialized industry.

The investment thesis centers on structural tailwinds: autism diagnoses among U.S. children nearly tripled between 2011 and 2022, while all 50 states enacted insurance mandates requiring commercial coverage of Applied Behavior Analysis (ABA) therapy. PE entry accelerated only after these mandates became established in the mid-2010s, enabling firms to acquire providers and immediately access predictable insurance reimbursement streams. Geographic clustering reveals deliberate market selection: California, Texas, Colorado, and Illinois—states with both higher childhood autism prevalence and fewer insurance coverage restrictions—account for disproportionate acquisition activity, suggesting PE firms strategically targeted jurisdictions with favorable reimbursement environments.

State regulatory response is now intensifying as policymakers confront potential fiscal and clinical consequences. Health economist Yashaswini Singh, a study co-author, emphasized the core concern: "We're dealing with children who are largely insured by Medicaid programs, so if private equity increases the intensity of care, what we're looking at are impacts to state Medicaid budgets down the road." PE ownership structures typically prioritize revenue growth through service expansion, raising questions about whether intensity of care aligns with clinical necessity or financial optimization. Additionally, the opacity surrounding PE ownership—limited public data on where acquisitions occur, ownership concentration, and outcome tracking—has created a regulatory vacuum that state legislatures and insurance commissioners are beginning to address through targeted regulatory frameworks.

The stakes extend beyond fiscal pressure to fundamental questions about market consolidation in pediatric health care. Unlike traditional PE targets in administrative or operational services, autism therapy directly affects vulnerable children and intersects multiple state systems—Medicaid, commercial insurance, education, and health departments. The concentration of 574 centers under PE ownership across a decade signals irreversible structural change in service delivery, making prospective state regulation critical to protecting both provider independence and service quality standards before consolidation becomes further entrenched.